Evaluating nutrition in patients after stem cell transplantation
Official title: A Survey of Nutritional Status of Patients After Hematopoietic Stem Cell Transplantation
Run by The First Affiliated Hospital of Soochow University · NCT04146870 · Data updated 2026-11-12
This study looks at the nutrition of patients who have had stem cell transplants to see how their eating habits and health changes affect their recovery over time.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 15 Years to 80 Years |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | The First Affiliated Hospital of Soochow University Academic / other |
| Locations | 1 site (Suzhou, Jiangsu) |
| Status | Recruiting |
| Started | October 1, 2018 |
| Main results expected | December 30, 2026 |
| Study ends | December 30, 2026 |
| Registry record updated | March 19, 2026 |
| Trial ID | NCT04146870 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are patients aged 15 to 80 who are undergoing hematopoietic stem cell transplantation at the First Affiliated Hospital of Soochow University.
✕Probably not a fit
Patients who are unwilling to participate or do not meet the age criteria may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to systematically assess the nutritional status of patients who have undergone hematopoietic stem cell transplantation at the First Affiliated Hospital of Soochow University. Evaluations will occur at multiple time points, including before the conditioning regimen and 180 days post-transplantation, focusing on factors such as food intake, physical activity, body composition, and blood biochemistry. Additionally, the study will explore how these nutritional factors may influence the prognosis of the patients.
Why it matters
Potential benefit: If successful, this study could lead to improved nutritional management strategies that enhance recovery and outcomes for patients after stem cell transplantation.
How similar studies have gone: While there may be studies on nutrition in transplant patients, this specific approach focusing on comprehensive nutritional evaluation post-transplantation is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients who undergo hematopoietic stem cell transplantation in the First Affiliated Hospital of Soochow University. * Having a life expectancy of more than 3 months Exclusion Criteria: * Not willing to participate in the investigation * Age less than 15 years old or more than 80 years old
Where it's running
-
The first affiliated hospital of suzhou university
Suzhou, Jiangsu, China Recruiting
Study contacts
- Study coordinator: Sheng-Li Xue, M.D.
- Email: slxue@suda.edu.cn
- Phone: +86 512 67781139
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Population PK-guided ATG Dosing in Haploidentical Stem Cell Transplant
This trial tests a population PK-guided ATG dosing strategy in people undergoing haploidentical hematopoietic stem cell transplantation to see if it improves outcomes.
-
Population PK-guided ATG Dosing in Haplo-HSCT
This study tests a population PK-guided dosing strategy for anti-thymocyte globulin (ATG) in adults and adolescents undergoing haploidentical stem cell transplantation to see if it can reduce GVHD while keeping relapse risk acceptable.
-
Low-dose liposomal amphotericin B to prevent invasive fungal infections in neutropenic children
This study tests whether giving a fixed low dose of liposomal amphotericin B can prevent invasive fungal infections in children aged 3–17 who are severely neutropenic after hematopoietic stem cell transplantation or similar high-risk conditions.
-
Personalized ATG dosing in unrelated donor stem cell transplants
This trial tests whether tailoring anti-thymocyte globulin dosing works better than standard fixed dosing in adults and adolescents receiving unrelated donor stem cell transplants.
-
Hematologic cancer survivors after stem cell transplant try a personalized care plan
This study tests a personalized Survivorship Care Plan for people with hematologic cancer who have undergone a stem cell transplant to see if it’s feasible within the Italian health system.
-
T-cell–guided letermovir stopping after allogeneic stem cell transplant
This tests whether using a CMV-specific T-cell blood test to decide when adult CMV-positive patients can stop letermovir after allogeneic stem cell transplant keeps them protected while avoiding unnecessary drug exposure.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.